Royal Bank of Canada’s Elevance Health ELV Stock Holding History

Royal Bank of Canada’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.62M	Sell	22,600 -26,000	-53%	-$8.55M	﹤0.01%	2209
2025 Q4	$17M	Buy	48,600 +1,000	+2%	+$338K	﹤0.01%	1602
2025 Q3	$15.4M	Sell	47,600 -700	-1%	-$218K	﹤0.01%	1858
2025 Q2	$18.8M	Buy	48,300 +700	+1%	+$282K	﹤0.01%	1576
2025 Q1	$20.7M	Hold	47,600	–	–	﹤0.01%	1279
2024 Q4	$17.6M	Buy	+47,600	New	+$19.9M	﹤0.01%	1434
2021 Q2	–	Sell	-3,400	Closed	-$1.22M	–	7531
2021 Q1	$1.22M	Buy	+3,400	New	+$1.09M	﹤0.01%	3408
2019 Q1	–	Sell	-100	Closed	-$26K	–	6878
2018 Q4	$26K	Sell	100 -200	-67%	-$55K	﹤0.01%	5450
2018 Q3	$82K	Hold	300	–	–	﹤0.01%	4970
2018 Q2	$71K	Sell	300 -35,600	-99%	-$8.24M	﹤0.01%	4992
2018 Q1	$7.89M	Buy	+35,900	New	+$8.43M	﹤0.01%	1696
2017 Q3	–	Sell	-28,400	Closed	-$5.34M	–	6764
2017 Q2	$5.34M	Buy	+28,400	New	+$5.1M	﹤0.01%	1903
2016 Q3	–	Sell	-29,000	Closed	-$3.81M	–	6430
2016 Q2	$3.81M	Buy	+29,000	New	+$3.97M	﹤0.01%	2070
2015 Q1	–	Sell	-26,300	Closed	-$3.31M	–	6203
2014 Q4	$3.31M	Hold	26,300	–	–	﹤0.01%	1943
2014 Q3	$3.15M	Hold	26,300	–	–	﹤0.01%	1962
2014 Q2	$2.83M	Buy	+26,300	New	+$2.71M	﹤0.01%	2038
2013 Q3	–	Sell	-31,700	Closed	-$2.59M	–	6131
2013 Q2	$2.59M	Buy	+31,700	New	+$2.37M	﹤0.01%	1891

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Royal Bank of Canada's ELV Position: Q1 2026 in Review

Royal Bank of Canada increased its Elevance Health (ELV) stake by 8.4% in Q1 2026, buying an estimated $12.6M and bringing the position to 495,383 shares worth $145M. The position accounts for 0.03% of the portfolio, ranked #510.

Royal Bank of Canada first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $519M in Q4 2022. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Royal Bank of Canada held 495,383 shares of Elevance Health worth $145M as of Q1 2026.
Royal Bank of Canada bought 38,283 Elevance Health shares in Q1 2026, an estimated $12.6M.
Elevance Health made up 0.03% of Royal Bank of Canada's portfolio in Q1 2026, its #510 holding.
Royal Bank of Canada first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's Elevance Health position peaked at $519M in Q4 2022.
1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.